Biotech · Public company · Boston, MA, US
Aura Biosciences, Inc.
Ticker AURA · SEC CIK 0001501796
Track this companyFree. Adds Aura Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials85 recruiting or active
Pipeline programs18From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline18
- Bel-sarPhase 3 · Choroidal MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- Infrared LaserPhase 3 · Choroidal MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- Sham Infrared LaserPhase 3 · Choroidal MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- Sham MicroinjectorPhase 3 · Choroidal MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- Suprachoroidal MicroinjectorPhase 3 · Choroidal MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- AU-011Phase 2 · Eye CancerClinicalTrials.gov · fetched Nov 12, 2026
- AU-011Phase 2 · Uveal MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- LaserPhase 2 · Eye CancerClinicalTrials.gov · fetched Nov 12, 2026
- Laser ActivationPhase 2 · Uveal MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- Light-activated AU-011Phase 2 · Uveal MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- PDT LaserPhase 2 · Uveal MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- SCS MicroinjectorPhase 2 · Eye CancerClinicalTrials.gov · fetched Nov 12, 2026
- Suprachoroidal MicroinjectorPhase 2 · Uveal MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- AU-011Phase 1 · Non-muscle-invasive Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- AU-011 in Combination with Medical Laser AdministrationPhase 1 · Non-muscle-invasive Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- AU-011 in Combination with Medical Laser AdminstrationPhase 1 · Non-muscle-invasive Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- AU-011Choroidal MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- ObservationalChoroidal MelanomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal MelanomaENROLLING_BY_INVITATION · started Mar 27, 2026ClinicalTrials.gov NCT07338968 · fetched Nov 12, 2026
- Suprachoroidal Administration in Subjects With Metastases to the ChoroidPHASE2 · RECRUITING · started Dec 16, 2024ClinicalTrials.gov NCT06643884 · fetched Nov 12, 2026
- A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal MelanomaPHASE3 · ACTIVE_NOT_RECRUITING · started Dec 6, 2023ClinicalTrials.gov NCT06007690 · fetched Nov 12, 2026
- A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Sep 26, 2022ClinicalTrials.gov NCT05483868 · fetched Nov 12, 2026
- Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM)TERMINATED · started Apr 14, 2022ClinicalTrials.gov NCT05266430 · fetched Nov 12, 2026
- Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal MelanomaPHASE2 · COMPLETED · started Aug 5, 2020ClinicalTrials.gov NCT04417530 · fetched Nov 12, 2026
- A Registry of Subjects With Primary Indeterminate Lesions or Choroidal MelanomaACTIVE_NOT_RECRUITING · started Mar 27, 2019ClinicalTrials.gov NCT03941379 · fetched Nov 12, 2026
- Study in Subjects With Small Primary Choroidal MelanomaPHASE1_PHASE2 · COMPLETED · started Feb 27, 2017ClinicalTrials.gov NCT03052127 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 8, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 11, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 4, 2026 · fetched Nov 12, 2026